Stirling Griff (SA, Nick Xenophon Team) Share this | Hansard source

Some chemotherapy treatments can now be administered through subcutaneous injection; however, this is not specifically covered in the MBS, so some funds are refusing to reimburse in-hospital costs for this kind of treatment. As a result, many patients are electing to have intravenous chemo to avoid out-of-pocket costs. Given the lower risks associated with subcutaneous injection, will the minister add this form of treatment to the MBS?